Biotech Values

[genisi]

Now that the FDA has rejected Teva's CP, we anticipate it will file another CP

I don't know why this analyst thinks that the FDA rejected the CP. It is my understanding that the FDA didn't reject the CP, rather it delayed its decision to a more appropriate time. I find the FDA response to be a non event to both sides. On one thing I do agree with the writer -

Teva likely submitted the CP seeking to stall M-356 in its regulatory pathway.